Safety and Tolerability of an Olmesartan Medoxomil-Based Regimen in Patients with Stage 1 Hypertension: A Randomized, Double-Blind, Placebo-Controlled Study

By Chrysant Steven G.  

Clinical Drug Investigation, Vol. 30, Iss. 7, 2010-07 ,pp. : 473-482

Adis International

Access to resources Recommend Favorite

Gabapentin Extended-Release Tablets for the Treatment of Patients with Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled, Multicentre Study

By Wallace Mark S.  

Clinical Drug Investigation, Vol. 30, Iss. 11, 2010-11 ,pp. : 765-776

Adis International

Access to resources Recommend Favorite

Safety, Tolerability and Pharmacokinetics of Dalcetrapib Following Single and Multiple Ascending Doses in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Phase I Study

By Derks Michael   Anzures-Cabrera Judith   Turnbull Lynn   Phelan Mary  

Clinical Drug Investigation, Vol. 31, Iss. 5, 2011-05 ,pp. : 325-335

Adis International

Access to resources Recommend Favorite

Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan

By Nakamura Yu   Kitamura Shin   Homma Akira   Shiosakai Kazuhito   Matsui Daiju  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 913-925

Informa Healthcare

Access to resources Recommend Favorite

Optimal Dosing of Galantamine in Patients with Mild or Moderate Alzheimer's Disease: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial

By Aronson Stephen  

Drugs & Aging, Vol. 26, Iss. 3, 2009-01 ,pp. : 231-239

Adis International

Access to resources Recommend Favorite